{"version":"1.0","type":"link","title":"A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.","author_name":"Johnson ML 외","author_url":"https://prs-insight.online/author/Johnson%20ML","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/94658","thumbnail_width":1200,"thumbnail_height":630}